The National Institute of Allergy and Infectious Diseases (NIAID) is interested in supporting preclinical studies utilizing animal models or human tissue specimens that focus on optimizing treatment and graft monitoring to reduce incidence of acute rejection and maximize graft survival after vascularized composite allotransplantation (VCA) and on minimizing immunosuppression required for long-term VCA acceptance.
Posting Date
Expiration Date
Last Reviewed Date
Funding Opportunity Type
Notice of Special Interest (NOSI)
Announcement Number
NOT-AI-22-023